QTc prolongation during ciprofloxacin and fluconazole combination therapy: prevalence and associated risk factors

AIM(S): Ciprofloxacin and fluconazole combination therapy is frequently used as prophylaxis for, and treatment of, infections in patients with haematological malignancies. However, both drugs are known to prolong the heart rate‐corrected QT (QTc) interval, which is a serious risk factor for torsade...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Clin Pharmacol
Main Authors: Berger, Florine A., Monadian, Nico, de Groot, Natasja M. S., Santbergen, Bart, van der Sijs, Heleen, Becker, Matthijs L., Broers, Annoek E. C., van Gelder, Teun, van den Bemt, Patricia M. L. A.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Drug Safety
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5777440/
https://ncbi.nlm.nih.gov/pubmed/29057492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13457
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados